✦ LIBER ✦

TRIO-012: A Multicenter, Multinational, Randomized, Double-Blind Phase III Study of IMC-1121B Plus Docetaxel Versus Placebo Plus Docetaxel in Previously Untreated Patients With HER2-Negative, Unresectable, Locally Recurrent or Metastatic Breast Cancer

✍ Scribed by John Mackey; Karen Gelmon; Miguel Martin; Nicole McCarthy; Tamas Pinter; Mathieu Rupin; Hagop Youssoufian

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, placebo-controlled, double

✍ Paul Ruff; D. A. Vorobiof; J. P. Jordaan; G. S. Demetriou; S. D. Moodley; A. L. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 225 KB

Rationale and Design of MARQUEE: A Phase

✍ Giorgio V. Scagliotti; Silvia Novello; Joan H. Schiller; Vera Hirsh; Lecia V. Se 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 332 KB